Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
USNA 
USANA Health Sciences Inc (USNA)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/14/2025: USNA (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
1 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $61
1 Year Target Price $61
| 0 | Strong Buy |
| 0 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -30.78% | Avg. Invested days 35 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 08/14/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 557.84M USD | Price to earnings Ratio 16.96 | 1Y Target Price 61 |
Price to earnings Ratio 16.96 | 1Y Target Price 61 | ||
Volume (30-day avg) 1 | Beta 0.61 | 52 Weeks Range 23.10 - 41.84 | Updated Date 08/15/2025 |
52 Weeks Range 23.10 - 41.84 | Updated Date 08/15/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 1.8 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-07-21 | When Before Market | Estimate 0.54 | Actual 0.74 |
Profitability
Profit Margin 3.79% | Operating Margin (TTM) 7.09% |
Management Effectiveness
Return on Assets (TTM) 5.14% | Return on Equity (TTM) 6.35% |
Valuation
Trailing PE 16.96 | Forward PE 11.7 | Enterprise Value 401226153 | Price to Sales(TTM) 0.62 |
Enterprise Value 401226153 | Price to Sales(TTM) 0.62 | ||
Enterprise Value to Revenue 0.45 | Enterprise Value to EBITDA 4.15 | Shares Outstanding 18271800 | Shares Floating 9498249 |
Shares Outstanding 18271800 | Shares Floating 9498249 | ||
Percent Insiders 42.93 | Percent Institutions 59.74 |
Upturn AI SWOT
USANA Health Sciences Inc
Company Overview
History and Background
USANA Health Sciences Inc. was founded in 1992 by Dr. Myron Wentz. Initially focused on diagnostic testing, it shifted to nutritional supplements. It experienced rapid growth through its multi-level marketing model.
Core Business Areas
- Nutritional Supplements: Development, manufacturing, and marketing of science-based nutritional supplements including vitamins, minerals, and antioxidants.
- Personal Care Products: Development, manufacturing, and marketing of personal care products, including skin and hair care.
Leadership and Structure
The company is led by CEO Jim Brown. The structure is a multi-level marketing organization with a hierarchical distributor network.
Top Products and Market Share
Key Offerings
- CellSentials: A core nutritional supplement providing essential vitamins, minerals, and antioxidants. Difficult to determine exact market share for this specific product. Competitors include Centrum, One A Day, and other multi-vitamin brands. Revenue data from USANA does not break down into specific product revenue. Globally, the dietary supplements market is fragmented. Estimated 1.5 million customers.
- Rev3 Energy: Energy drink focused on healthy alternatives to traditional energy drinks. USANA doesn't report specific product revenue. Competitors include Red Bull, Monster, and other energy drink brands.
- Celavive Skincare: Skincare line focusing on advanced skincare formulations. USANA doesn't report specific product revenue. Competitors include Proactiv, L'Oreal, and other skincare brands.
Market Dynamics
Industry Overview
The nutritional supplement industry is large and growing, driven by increasing health awareness and an aging population. It is also highly competitive and subject to regulatory scrutiny.
Positioning
USANA is positioned as a premium brand offering science-based nutritional supplements. Its competitive advantage is its multi-level marketing distribution model.
Total Addressable Market (TAM)
The global dietary supplements market is estimated to reach hundreds of billions of USD. USANA captures a small fraction of this TAM, positioning itself in the premium end of the market.
Upturn SWOT Analysis
Strengths
- Strong brand reputation
- Science-based formulations
- Multi-level marketing distribution network
- Global presence
Weaknesses
- Reliance on distributor network
- Susceptibility to regulatory changes
- Potential for brand damage from distributor misconduct
- Higher price point compared to some competitors
Opportunities
- Expansion into new markets
- Development of new products
- Partnerships with healthcare professionals
- Increased focus on online sales
Threats
- Increased competition
- Changing consumer preferences
- Negative publicity
- Economic downturns
- Regulatory crackdown on nutritional supplement claims
Competitors and Market Share
Key Competitors
- HLF
- NUTR
- GNC
Competitive Landscape
USANA competes with a wide range of companies in the nutritional supplement industry. It differentiates itself through its science-based formulations and multi-level marketing model. However, large competitors like HLF have larger global distribution and financial resourcs.
Growth Trajectory and Initiatives
Historical Growth: USANA has experienced periods of rapid growth followed by periods of slower growth. Growth has generally been tied to global economic activity.
Future Projections: Analyst estimates vary, but generally project moderate growth for USANA in the coming years.
Recent Initiatives: Recent initiatives include focusing on new products and market segments.
Summary
USANA is a well-established nutritional supplement company with a strong brand and unique distribution model. However, it faces increasing competition and regulatory scrutiny. The company's success depends on its ability to innovate, expand into new markets, and effectively manage its distributor network.
Peer Comparison
Sources and Disclaimers
Data Sources:
- USANA Health Sciences Inc. Investor Relations, Company 10-K filings, Analyst Reports, Market Research Reports
Disclaimers:
This analysis is for informational purposes only and should not be considered investment advice. Market data and share information are subject to change. The AI-based rating is based on a specific algorithm and should not be the sole basis for investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About USANA Health Sciences Inc
Exchange NYSE | Headquaters Salt Lake City, UT, United States | ||
IPO Launch date 1996-07-25 | CEO & President Mr. Jim Brown | ||
Sector Consumer Defensive | Industry Packaged Foods | Full time employees 1700 | Website https://www.usana.com |
Full time employees 1700 | Website https://www.usana.com | ||
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Direct selling and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It also provides Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.